In noncritical COVID-19, therapeutic vs. prophylactic anticoagulation did not reduce a composite adverse clinical outcome at 30 d

Stone GW, Farkouh ME, Lala A, et al; FREEDOM COVID Anticoagulation Strategy Randomized Trial Investigators. J Am Coll Cardiol. 2023;81:1747-1762. 36889611.

Saved in:
Bibliographic Details
Published inAnnals of internal medicine Vol. 176; no. 8; p. JC93
Main Author DeLoughery, Thomas G
Format Journal Article
LanguageEnglish
Published United States 01.08.2023
Subjects
Anticoagulants - adverse effects
COVID-19
Humans
Online AccessGet more information

Cover

More Information
Summary:Stone GW, Farkouh ME, Lala A, et al; FREEDOM COVID Anticoagulation Strategy Randomized Trial Investigators. J Am Coll Cardiol. 2023;81:1747-1762. 36889611.
ISSN:1539-3704
DOI:10.7326/J23-0059